Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
  • A61K31/19—Carboxylic acids, e.g. valproic acid
  • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
  • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
  • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/13—Amines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
  • A61P25/16—Anti-Parkinson drugs
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

• Health & Medical Sciences (AREA)
• Neurosurgery (AREA)
• Neurology (AREA)
• Biomedical Technology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Engineering & Computer Science (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Epidemiology (AREA)
• Psychology (AREA)
• Hospice & Palliative Care (AREA)
• Psychiatry (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=66174216

Family Applications (1)

Country Status (24)

Families Citing this family (4)

Family Cites Families (10)

• 2018
  • 2018-02-15 AU AU2018351709A patent/AU2018351709B2/en active Active
  • 2018-02-15 MA MA50383A patent/MA50383B1/fr unknown
  • 2018-02-15 ES ES18708286T patent/ES3057584T3/es active Active
  • 2018-02-15 CN CN201880081672.6A patent/CN111542314B/zh active Active
  • 2018-02-15 WO PCT/US2018/018420 patent/WO2019078915A1/en not_active Ceased
  • 2018-02-15 MX MX2020003427A patent/MX2020003427A/es unknown
  • 2018-02-15 JP JP2020521938A patent/JP2021500342A/ja active Pending
  • 2018-02-15 RU RU2020115710A patent/RU2763425C2/ru active
  • 2018-02-15 US US16/756,948 patent/US11793782B2/en active Active
  • 2018-02-15 CA CA3079194A patent/CA3079194A1/en active Pending
  • 2018-02-15 SG SG11202003390UA patent/SG11202003390UA/en unknown
  • 2018-02-15 FI FIEP18708286.2T patent/FI3697399T3/fi active
  • 2018-02-15 PL PL18708286.2T patent/PL3697399T3/pl unknown
  • 2018-02-15 SM SM20250483T patent/SMT202500483T1/it unknown
  • 2018-02-15 MD MDE20200852T patent/MD3697399T2/ro unknown
  • 2018-02-15 DK DK18708286.2T patent/DK3697399T3/da active
  • 2018-02-15 EP EP18708286.2A patent/EP3697399B1/en active Active
  • 2018-02-15 EP EP24192081.8A patent/EP4467138A3/en active Pending
  • 2018-02-15 RS RS20251349A patent/RS67601B1/sr unknown
  • 2018-02-15 KR KR1020207014143A patent/KR102549684B1/ko active Active
  • 2018-02-15 IL IL273929A patent/IL273929B2/en unknown
  • 2018-02-15 HR HRP20251695TT patent/HRP20251695T1/hr unknown
  • 2018-02-15 SI SI201831286T patent/SI3697399T1/sl unknown
  • 2018-02-15 PT PT187082862T patent/PT3697399T/pt unknown
  • 2018-02-15 LT LTEPPCT/US2018/018420T patent/LT3697399T/lt unknown

Also Published As

Similar Documents